All Type of News
KFDA to amend Korean Pharmacopoeia
The Korea Food and Drug Administration will revise the Korean Pharmacopoeia by ameliorating the testing methods of 28 medicinal products, such as heavy metals, impurities and microbial limits.
The KFDA said this is...
Trade deal will corner local drug makers
Domestic drug makers should be encouraged to focus on research and development of new drugs to survive in an era of the free trade agreements, experts said.
They should pursue the knowledge-intensive industry base...
Choong-wae to conduct large-scale clinical study with pitavastatin
Choong-wae Pharm announced on July 14 that it will conduct the first clinical trial specifically designed to study the efficacy of pitavastatin that may reduce the risk of cardiovascular events in 2,000 Korean patient...
Pharmaceutical wholesalers promises to clean house
The wholesaling industry pledged to improve unethical practices in the pharmaceutical business.
The Korea Association of Pharmaceutical Wholesaler and its leading 30 wholesalers plan to hold a convention on July 28...
Joint bioequivalence testing to be permitted next year
The Korea Food and Drug Administration said that the joint bioequivalence testing, which has been implemented on a limited basis, would be fully utilized by those companies which may cope with the new guideline to be ...
Green Cross holds launching symposium over Abraxane
Green Cross holds launching symposium over Abraxane
Green Cross Corporation held its symposium for Abraxane, paclitaxel protein-bound particles for injectable suspension, at Grand Intercontinental hotel on July 10....
Taksen takes on other NSAIDs
Green Cross Corporation is enjoying brisk sales of its non-steroidal anti-inflammatory drug (NSAID), Taksen.
Sales of GCC’s Taksen reached over 3 billion won since its release in November 2007, making it one of th...
Second results of drug utilization review to be evaluated
The Ministry of Health, Welfare and Family Affairs plans to assess the second results of drug utilization review (DUR).
Under the plan, a reliable private organization to be selected by the health ministry will be ...
1,133 drugs registered in KPIC in first half
The Korea Pharmaceutical Information Center (KPIC) said on July 13 that a total of 1,133 medicines in the form of solid forms (tablets or capsules) were newly registered to the KPIC in the January-June period, under t...
US Bio association expresses negative response on biosimilars
The US Senate introduced a bipartisan bill on March 26, 2009, which establishes a regulatory pathway for approval of biosimilars.
A key provision in the Senate bill is to establish five years of market exclusivity ...
